Tianjin Economic-Technological Development Area has announced that the Umbilical Cord Mesenchymal Stem Cell Bank in China, an important component of the national stem cell system project, has been established in Tianjin University Science Park in the Tianjin Economic-Technological Development Area.
This achievement follows on from the establishment and opening of the advanced stem cell bank, with the largest Umbilical Cord Blood Hemopoietic Stem Cell Bank, in 2001.
The bank will considerably improve the diagnosis and treatment of stem cell products for malignant hemopathies, immunodeficiency diseases, hereditary diseases, and malignant tumors etc., and will accelerate conversion of achievements of stem cell-related technologies and genetic engineering-related research into practical productive forces.
The Umbilical Cord Mesenchymal Stem Cell Bank has been approved as a project by the National Development and Reform Commission.
Its total reserve capacity of Phase I is 40,000 sets with a daily treatment capacity of 20 sets; the total reserve capacity of Phase II is expected to be over 500,000 sets with a daily treatment capacity of 300 sets.
The stem cell treatment center is built strictly according to standards of Good Manufacturing Practice and Quality Control, having around 760 square meters of class 10,000 and local class 100 highly clean areas; main instruments and equipment are all world class products; typing laboratory of the stem cell bank is equipped in strict accordance with standards concerning gene diagnosis laboratories issued by the Ministry of Health, reaching domestic first class HLA typing laboratory levels.